| Biomaterials are used to help regenerate or replace the structure and function of damaged tissues. In order to elicit desired therapeutic responses in vivo, biomaterials are often functionalized with bioactive agents, such as growth factors, small molecule drugs, or even stem cells. Therefore, the strategies used to incorporate these bioactive agents in the microstructures and nanostructures of biomaterials can strongly influence the their therapeutic efficacy. Using self-assembling peptide amphiphiles (PAs), this work has investigated supramolecular nanostructures with improved interaction with three types of therapeutic agents: bone morphogenetic protein 2 (BMP-2) which promotes osteogenic differentiation and bone growth, anti-inflammatory drug naproxen which is used to treat osteo- and rheumatoid arthritis, and neural stem cells that could differentiate into neurons to treat neurodegenerative diseases. For BMP-2 delivery, two specific systems were investigated with affinity for BMP-2: 1) heparin-binding nanofibers that display the natural ligand of the osteogenic protein, and 2) nanofibers that display a synthetic peptide ligand discovered in our laboratory through phage display to directly bind BMP-2. Both systems promoted enhanced osteoblast differentiation of pluripotent C2C12 cells and augmented bone regeneration in two in vivo models, a rat critical-size femur defect model and spinal arthrodesis model. The thesis also describes the use of PA nanofibers to improve the delivery of the anti-inflammatory drug naproxen. To promote a controlled release, naproxen was chemically conjugated to the nanofiber surface via an ester bond that would only be cleaved by esterases, which are enzymes found naturally in the body. In the absence of esterases, the naproxen remained conjugated to the nanofibers and was non-bioactive. On the other hand, in the presence of esterases, naproxen was slowly released and inhibited cyclooxygenase-2 (COX-2) activity, an enzyme responsible for inflammation. Finally, PA nanofibers were utilized as synthetic extracellular matrices (ECM) to encapsulate neural stem cells and promote neuron differentiation. Here, the influence of ECM nanostructures on neuron differentiation was assessed by comparing wide and narrow nanoribbons that were crafted from identical PA molecules. The PAs self-assembled into wide nanoribbons at pH 6.6, but raising the pH to 7.2 promoted increased side-chain ionization and electrostatic repulsion, thus resulting in a structural transformation into thin nanoribbons. In contrast, introducing divalent Ca2+ counterions at pH 6.6 stabilized the intermolecular cohesion of the PA molecules and the wide nanoribbon shape was preserved upon increasing pH. Interestingly, the wide nanoribbon gel exhibited a higher stiffness than the narrow nanoribbon gel. When neural stem cells were encapsulated, the wide nanoribbon matrix was able to promote neuron differentiation, while the thin nanoribbon matrix contracted and prevented neuron differentiation. Mechanistically, the collapse of the thin ribbons likely increased the local density and cell-cell contact of the stem cells, which has been found previously to prevent differentiation into neuronal lineage. Taken together, these findings demonstrate the significance of protein-material or cell-material interactions in achieving optimal therapeutic effects and provide future strategies for developing functional supramolecular biomaterials. |
